NASDAQ · Analyst Forecast

Bio-Techne Corp (TECH) Stock Forecast & Price Target

$72.63 NASDAQ: TECH Market Cap $11.41B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 15, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Bio-Techne Corp (TECH), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Bio-Techne Corp, analysts forecast revenue rising from $1.21B in 2026 to $1.96B in 2031; the average estimate for 2031 earnings per share is $0.00; 10 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$72.63
Consensus targetThe average of the price targets analysts have published.$71.67
Median targetThe middle target, less affected by a single outlier.$73.00
Highest targetThe most optimistic published target.$73.00
Lowest targetThe most pessimistic published target.$65.00
Difference from priceHow far the consensus target sits from today’s price.-1.3%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2026$1.20B$1.21B$1.22B10
2027$1.25B$1.27B$1.29B5
2028$1.39B$1.40B$1.43B7
2029$1.50B$1.57B$1.65B4
2030$1.68B$1.72B$1.78B2
2031$1.92B$1.96B$2.03B1

Earnings per share forecast

YearLowAverageHighAnalysts
2026$1.87$1.92$1.9510
2027$1.86$2.05$2.205
2028$2.20$2.36$2.497
2029$2.37$2.45$2.574
2030$2.61$2.69$2.822
2031$0.00$0.00$0.001

Bio-Techne Corp (TECH) forecast — frequently asked questions

What is the analyst price target for Bio-Techne Corp?

Analysts covering Bio-Techne Corp (TECH) have a consensus price target of $71.67, 1.3% below the current price of $72.63. Published targets range from $65.00 to $73.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Bio-Techne Corp's earnings?

The average analyst estimate for Bio-Techne Corp (TECH) earnings per share in 2031 is 0.00, with individual estimates between 0.00 and 0.00.

How much revenue is Bio-Techne Corp expected to make?

Analysts forecast Bio-Techne Corp (TECH) revenue of $1.96B in 2031, based on 1 published estimates.

How many analysts cover TECH?

10 analysts contribute estimates for Bio-Techne Corp (TECH). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.